Skip to content

Eli Lilly LLY Debt-to-assets

Debt-to-assets at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
0.3×0.0×
Pfizer logo
PfizerPFE
0.3×0.0×
Amgen logo
AmgenAMGN
0.6×0.0×
Cardinal Health logo
Cardinal HealthCAH
0.2×0.0×
Biogen logo
BiogenBIIB
0.2×0.0×
McKesson logo
McKessonMCK
-0.1×

Other financials

Income statement

See full
Revenue$19.8B+55.5%
Gross profit$16.2B+54.4%
Net income$7.4B+168%
EPS (diluted)$8.26+170%

Balance sheet

See full
Cash & equivalents$5.3B+70.8%
Total debt$43.4B+12.6%
Total equity$31.2B+97.9%
Total assets$116.58B+30.4%

Cash flow

See full
Operating cash flow$5.3B+220%
CapEx$2.3B+54.0%
Free cash flow$3.0B+1,828%

Valuation

See full
Market cap$979.64B+10.8%
Enterprise value$1.02T+10.6%
P/E38.8×-40.9×
P/S13.6×-4.5×

Profitability

See full
Gross margin82.8%+1.1pp
Net margin35%+12.3pp

Returns & leverage

See full
Return on equity107.6%+29.9pp
Debt / equity1.4×-1.1×
Current ratio1.5×+0.1×

Where this comes from

Calculated from Eli Lilly’s reported figures.

Based on the most recent quarter.

The official record: Eli Lilly’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Eli Lilly's debt-to-assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Eli Lilly's debt-to-assets?
Eli Lilly (LLY) reported debt-to-assets of 0.4× in Q1 2026.
How has Eli Lilly's debt-to-assets changed year-over-year?
Eli Lilly's debt-to-assets decreased by 13.7% year-over-year, from 0.4× to 0.4×.
What is the long-term trend for Eli Lilly's debt-to-assets?
Over 4 years (2021 to 2025), Eli Lilly's debt-to-assets has grown at a 2.9% compound annual growth rate (CAGR), from 1.4× to 1.6×.
What does debt-to-assets mean?
What fraction of everything the company owns is funded by debt.
How do you interpret debt-to-assets?
A lower ratio indicates a more conservatively financed balance sheet. Rising debt-to-assets over time signals increasing financial risk.
How does debt-to-assets compare across companies?
Comparable within an industry; bounded between 0 and 1 for most non-financials, which makes cross-company reads cleaner than debt-to-equity.